The ChIP assay showed that the IRF1-targeting ITLN1 promoter regions were immunoprecipitated by the antibody specific to IRF1 when compared to an unspecific antibody (isotype IgG) in cultured HCC cells (Fig. 5B). The gene discussed is ITLN1; the disease is hepatocellular carcinoma.